Chase Cochrane
2.2K posts

Chase Cochrane
@chasecochrane
Former D1 football Biomed background Peptides, performance, longevity




Your peptide vendor hands you a purity certificate. 99% pure. You inject it. 6,487 samples tested across 15 months: -> 71% failed drug manufacturing standards -> TB-500 passed just 7.5% of the time -> 15% had bacterial contamination -> Purity had zero connection to contamination A vial can pass every purity test and still be full of bacterial toxins. That certificate covers 2 of 10 @US_FDA quality checks. Sterility, potency, stability: nobody looked. We have more human pharmacology data on fentanyl than on BPC-157. That's not a hot take. That's a direct line from the researchers who ran this study. The label says "not for human consumption." That part, at least, appears accurate.




3 Months on Retatrutide


The New Yorker just lab-tested research peptides from a popular online vendor. BPC-157: contained lead. TB-500: contained endotoxins. CJC-1295: less than 42% of the labeled dose. This is what people are injecting into their bodies. The peptides aren't the problem. The supply chain is. This is exactly why the FDA reclassification matters moving these compounds into regulated compounding pharmacies with cGMP standards and real quality control.



🚨 BREAKING: FDA IS EXPECTED TO LIFT RESTRICTION ON PEPTIDES - NEW YORK TIMES $HIMS $LLY $NVO




















